Correlation of active caspase-3 to cytochrome c release, caspase dependent (ac to ccdep)
| . | n . | rs . | P . |
|---|---|---|---|
| Total | 45 | 0.360* | .015 |
| tp1, BM blast cells | |||
| Less than 5% | 28 | 0.568* | .002 |
| Greater than 5% | 9 | 0.548 | .127 |
| tp1, MRD (flow cytometry) | |||
| Negative | 13 | 0.642* | .018 |
| Positive | 23 | 0.358 | .094 |
| tp2, BM blast cells | |||
| Less than 5% | 14 | 0.646* | .043 |
| Greater than 5% | 21 | 0.287 | .124 |
| tp2, MRD (flow cytometry) | |||
| Negative | 14 | 0.528* | .014 |
| Positive | 21 | 0.055 | .851 |
| tp3, BM blast cells | |||
| Less than 5% | 26 | 0.619* | .006 |
| Greater than 5% | 14 | -0.094 | .750 |
| tp3, MRD (flow cytometry) | |||
| Negative | 8 | 0.764* | .027 |
| Positive | 12 | 0.267 | .402 |
| tp4, BM blast cells | |||
| Less than 5% | 36 | 0.497* | .002 |
| Greater than 5% | 4 | -0.258 | .742 |
| tp4, MRD (flow cytometry) | |||
| Negative | 23 | 0.386 | .069 |
| Positive | 7 | -0.204 | .661 |
| CR | |||
| Yes | 40 | 0.352* | .026 |
| No | 5 | 0.0 | .000 |
| Duration of CR, (solely CR patients) | |||
| More than 1 year | 32 | 0.460* | .008 |
| Less than 1year | 8 | -0.074 | .862 |
| Relapse | |||
| No | 28 | 0.519* | .005 |
| Yes | 12 | 0.134 | .679 |
| Relapse within 24 months after diagnosis | |||
| No | 29 | 0.516* | .004 |
| Yes | 11 | 0.070 | .838 |
| . | n . | rs . | P . |
|---|---|---|---|
| Total | 45 | 0.360* | .015 |
| tp1, BM blast cells | |||
| Less than 5% | 28 | 0.568* | .002 |
| Greater than 5% | 9 | 0.548 | .127 |
| tp1, MRD (flow cytometry) | |||
| Negative | 13 | 0.642* | .018 |
| Positive | 23 | 0.358 | .094 |
| tp2, BM blast cells | |||
| Less than 5% | 14 | 0.646* | .043 |
| Greater than 5% | 21 | 0.287 | .124 |
| tp2, MRD (flow cytometry) | |||
| Negative | 14 | 0.528* | .014 |
| Positive | 21 | 0.055 | .851 |
| tp3, BM blast cells | |||
| Less than 5% | 26 | 0.619* | .006 |
| Greater than 5% | 14 | -0.094 | .750 |
| tp3, MRD (flow cytometry) | |||
| Negative | 8 | 0.764* | .027 |
| Positive | 12 | 0.267 | .402 |
| tp4, BM blast cells | |||
| Less than 5% | 36 | 0.497* | .002 |
| Greater than 5% | 4 | -0.258 | .742 |
| tp4, MRD (flow cytometry) | |||
| Negative | 23 | 0.386 | .069 |
| Positive | 7 | -0.204 | .661 |
| CR | |||
| Yes | 40 | 0.352* | .026 |
| No | 5 | 0.0 | .000 |
| Duration of CR, (solely CR patients) | |||
| More than 1 year | 32 | 0.460* | .008 |
| Less than 1year | 8 | -0.074 | .862 |
| Relapse | |||
| No | 28 | 0.519* | .005 |
| Yes | 12 | 0.134 | .679 |
| Relapse within 24 months after diagnosis | |||
| No | 29 | 0.516* | .004 |
| Yes | 11 | 0.070 | .838 |
rs indicates correlation coefficient; and P, significance.
Correlation is significant (2-tailed).